Get started
Work

Safety and effectiveness of fuzuloparib in patients with ovarian cancer: A nationwide, multicenter, prospective real-world study.

Year: 2025
Type: conference-abstract
DOI: 10.1200/jco.2025.43.16_suppl.5572
Authors: Qinglei Gao, Jie Jiang, Mingqian Lu, Zhe Guo, Yingjie Yang, Pengchao Hu, Gongbin Chen, Ming Liu, Huifen Wang, Liang Chen, Xiaoling Li, Yutao Guan, Li Sun, Jun Tian, Quan Li, Qiubo Lv, Lixia Ma, Ding Ma
Institutions: Tongji Hospital, Huazhong University of Science and Technology, Qilu Hospital of Shandong University, Yichang Central People's Hospital, Guiyang Medical University, Guizhou Cancer Hospital, Hubei University of Medicine, Xiang Yang No.1 People's Hospital, Shangqiu First People's Hospital, Shandong University, Shandong Provincial Hospital, Luohe Medical College, Shandong Tumor Hospital, Shandong First Medical University, Ningbo University, Ningbo University Affiliated Hospital, Ningbo First Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Henan University, Xiangyang Central Hospital, Beijing Hospital, Hebei Medical University, Xingtai People's Hospital
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4410813019
Cites:
Cited by:
Related to: 10